4.6 C
January 28, 2022

Antibiotice Iasi Jan-Sept. net profit up 233.9 pc

Medicine manufacturer Antibiotice Iasi (ATB) posted a Jan.-Sept. after-tax profit of RON 21.11 M, up 33.9 per cent from year-on-year, for a turnover higher by 12.4 per cent, at RON 177.32 M, according to financial information remitted to the Bucharest Stock Exchange and cited by Agerpres. The company exceeded since as early as the first-half its net profit RON 14.7 M estimate for the whole year. Under the company’s revenue and spending budget, the turnover is likely to rise 9.2 pc, to RON 240 M.

Related posts

Allinso builds factory in Ploiesti

Nine O' Clock

Erste Group integrally repays the participative capital

Nine O' Clock

Suciu Popa wins two awards from Benchmark Litigation